For citations:
Nasretdinov AF, Sultanbaev AV, Musin SI, Menshikov KV, Ayupov RT, Izmailov AA, Serebrennikov GA, Askarov VE, Feoktistov DV. Evolution of therapy for ALK-positive lung carcinomas: Application of third-generation ALK inhibitors in real clinical practice. Meditsinskiy sovet = Medical Council. 2024;(10):74-80. (In Russ.) https://doi.org/10.21518/ms2024-251